

Learn how to save money on Cyltezo Pen 40 Mg/0.4 Ml Starter Pack in 2026. Explore copay cards, patient assistance programs, and other discount options.
Let's talk about the number that probably brought you here: Cyltezo Pen 40 Mg/0.4 Ml Starter Pack can cost $5,800 to $6,500 per month without insurance. Even with insurance, specialty tier copays can run $200 to $500 or more per fill. That's a significant financial burden, especially for a medication you may need for months or years.
The good news? There are multiple ways to reduce what you pay for Cyltezo in 2026. This guide walks you through every major savings option — from manufacturer copay cards to patient assistance programs to practical tips that can save you hundreds or even thousands of dollars.
Here's what you're looking at for Cyltezo Pen 40 Mg/0.4 Ml Starter Pack at full retail price:
For comparison, the original Humira lists at approximately $6,900 to $7,200 per month. As a biosimilar, Cyltezo is typically 5-15% less expensive at list price, but that discount alone doesn't make it affordable for most uninsured patients.
With commercial insurance, your out-of-pocket cost depends on your plan structure:
This is the first place to start if you have commercial insurance.
Boehringer Ingelheim offers a Cyltezo copay savings card for eligible commercially insured patients. Key details:
Important note about copay accumulators: Some insurance plans use copay accumulator programs that prevent manufacturer copay assistance from counting toward your deductible or out-of-pocket maximum. If your plan has a copay accumulator, you may face high costs once the manufacturer's assistance runs out. Ask your insurance company specifically about this.
If you're uninsured or underinsured, the Boehringer Ingelheim Cares Foundation may provide Cyltezo at no cost.
This is the best option for uninsured patients. Don't skip it — the application is straightforward and the savings are massive.
For patients who don't qualify for the manufacturer programs, several prescription discount platforms may offer some savings on Cyltezo:
A word of caution: Discount cards have limited impact on specialty biologic pricing. The savings from these cards on a $6,000+ medication may be modest. However, they're always worth checking — even small percentage savings on an expensive drug can add up.
If Cyltezo is particularly expensive on your plan, ask your doctor about other adalimumab biosimilars that may have better formulary placement — and therefore lower copays. Products like Amjevita, Hadlima, and Hyrimoz may be preferred on your plan with lower cost-sharing. Read our guide on alternatives to Cyltezo for more details.
Not all specialty pharmacies charge the same price. Use Medfinder to compare prices across pharmacies that stock Cyltezo. Even among in-network options, there can be meaningful price differences.
If you have a plan with a deductible and out-of-pocket maximum, starting Cyltezo early in the plan year can help you hit your out-of-pocket max sooner — meaning the rest of the year's doses may be fully covered.
Several organizations help patients with chronic conditions afford their medications:
If your insurance assigns Cyltezo to a specialty tier with high cost-sharing, you can appeal. Your doctor can submit a letter explaining the medical necessity and requesting a lower tier exception. Success rates vary, but it's always worth trying.
Some states have pharmaceutical assistance programs for residents with chronic conditions. These vary by state but can provide additional support beyond federal programs. Check with your state's Department of Health or Department of Insurance.
No one should have to choose between their health and their finances. Cyltezo Pen 40 Mg/0.4 Ml Starter Pack is an expensive medication, but there are real ways to bring the cost down — sometimes to zero.
Start with the Boehringer Ingelheim copay card if you have commercial insurance, or the Cares Foundation if you're uninsured. Explore nonprofit assistance programs. And always compare prices using Medfinder before filling your prescription.
If cost remains a barrier even after exploring these options, talk to your doctor about alternative adalimumab products that may be more affordable on your specific plan. The goal is keeping you on effective TNF-inhibitor therapy — whatever form that takes.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.